Huili Bio is a next-generation synthetic biology enzyme computational design platform, founded in 2018. Specializing in the biotechnology sector, the startup recently secured a significant CNY300.00M Series A investment on July 7, 2022. The investment was backed by a consortium of prominent investors including ZWC Partners, Cenova, Legend Capital, BioTrack Capital, and Yunqi Partners.
Huili Bio
Huili Bio is a next-generation synthetic biology enzyme computational design platform.
Founded 2018
Series A
Total: $300.00M
Biotechnology, Life Sciences
General Information
Company Name
Huili Bio
Founded Year
2018
Industries
Biotechnology, Life Sciences
Funding Stage
Series A
BounceWatch is an independent company data service, not affiliated with Huili Bio. To contact Huili Bio, visit huilibio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Huili Bio compare?
A PDF of Huili Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Huili Bio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Huili Bio
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | CNY300.00M | 5 |
|
07 Jul 2022 |
Huili Bio Alternatives & Competitors
View All Alternatives
Huili Bio vs
Computational biology to design new drugs.
Pre-Seed
1 employees
Biotechnology, Health and Wellness
Huili Bio vs
Syntensor
United Kingdom
Synthetic biology + systems ML
Seed
9 employees
Biotechnology, Life Sciences
Huili Bio vs
Strand Therapeutics
United States
Where synthetic biology meets RNA therapeutics
Series A
121 employees
Biotechnology, Health and Wellness
FAQ About Huili Bio
Huili Bio is a next-generation synthetic biology enzyme computational design platform.
Huili Bio was founded in 2018.
Huili Bio operates in Biotechnology and Life Sciences.
Huili Bio has completed 1 funding round, raising a total of $300.00M. The latest funding stage is Series A.
Top alternatives and competitors to Huili Bio include Biophysical Therapeutics, Syntensor, Strand Therapeutics, DNA Script, ELEGEN. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Huili Bio and Biophysical Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Huili Bio, https://bouncewatch.com/company/huili-bio, updated 10 November 2024. When citing, please name BounceWatch and link this page.
